Quant'AbondanceL'abondance, quantifiée.

Actualités

Uniquement les titres à fort signal - événements macro, résultats, M&A, régulation. Listicles et clickbait d'analystes filtrés par défaut. Rafraîchi toutes les heures.

23,580 signal articles · 326 in last 24h · 112,379 total before filter · latest 56m ago
326last 24h
2137last 7d
376● bullish (7d)
188● bearish (7d)
204publishers
AllMacro294Earnings1216M&A91Regulatory23Product13Analyst20
✕ clear all filtersticker: ABBVSentiment:bullishneutralbearish✓ showing all (incl. clickbait)
AbbVie’s (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm
Insider Monkey51d agobullish
AbbVie’s (ABBV) Allergan Aesthetics Wins FDA Approval for Skinvive by Juvederm

AbbVie Inc. (NYSE:ABBV) is one of the 12 High Quality Stocks to Buy for the Long Term. On June 16, 2026, Allergan Aesthetics, an AbbVie Inc. (NYSE:ABBV) company, announced the U.S. FDA approval of Skinvive by Juvederm to reduce neck lines and improve neck appearance in adults over the age of 21. AbbVie said Skinvive […]